dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

Pöördumise edastamine

Sotsiaalministeerium · 21. detsember 2020
Viit
1.4-2/3707-1
Registreeritud
21. detsember 2020
Dokumendi liik
Sissetulev kiri
Adressaat
Välisministeerium
Saabumis/saatmisviis
DVK
Funktsioon
1.4 EL otsustusprotsess ja rahvusvaheline koostöö
Sari
1.4-2 Rahvusvahelise koostöö korraldamisega seotud kirjavahetus (Arhiiviväärtuslik)
Toimik
1.4-2/2020
Vastutaja
Hanna Alajõe (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Euroopa Liidu ja väliskoostöö osakond)
Lahendamise tähtaeg
20. jaanuar 2021

Failid

  • 📎1247-1_kaaskiri.pdf316 KB
  • 📎1247-1_voliniku_kiri_ministrile.pdf212 KB

Sisu (failidest)

Tanel Kiik Sotsiaalminister Sotsiaalministeerium 21.12.2020 nr 10.1-13/1247-1 Austatud härra minister Edastame Teile Euroopa Komisjoni voliniku Stella Kyriakidese 19.12.2020 kirja nr Ares(2020) 7795830. Lugupidamisega Marten Kokk Esinduse asejuht Coreper I küsimustes Lisa: voliniku kiri 2 lehel Kersti Neeme +32 2227 4342 [email protected] Rue Guimard 11/13 1040 Brüssel Tel: +32 2 227 39 10 [email protected] https://eu.mfa.ee/et/ Ref. Ares(2020)7795830 - 19/12/2020 STELLA KYRIAKIDES Rue de la Loi, 200 MEMBER OF THE EUROPEAN COMMISSION B-1049 Brussels – Berl 10/380 HEALTH AND FOOD SAFETY [email protected] Brussels, Dear Minister Kiik, I hope this letter finds you, your family and colleagues in good health during these difficult times. I would like to thank you for your close cooperation throughout this crisis, which has allowed us to overcome many obstacles together. Our close cooperation shows that EU solidarity is strong and indispensable in overcoming challenges, including public health emergencies. The work that we are doing to ensure that safe and performant medical devices are continuously available on the market highlights the importance of this sector for the safety and health of all Europeans. This is the case not only in times of health crises, but also in the day-to-day functioning of health systems. As discussed during the informal Health Ministers’ meeting of 2 December, it is now time to turn our attention to the effective implementation of the new regulatory framework on medical devices. The Medical Devices Regulation (MDR), which was set to apply from 26 May 2020, was postponed by one year as a necessary measure at an exceptional moment in time. I wish to thank you for the very efficient inter-institutional co-operation in getting this measure adopted so swiftly. The decision has helped to ensure that safe and essential medical devices could continue to be placed on the EU market during COVID-19. It has also allowed the already stretched resources of the national competent authorities, notified bodies, manufacturers and other actors to fully prioritise and focus their efforts on the COVID-19 pandemic. Yet, there are two specific issues which remain particularly challenging: First, the designation of notified bodies under the new regulations is an essential element of the medical devices regulation and an extensive, intricate and demanding process, which requires joint assessments of candidate notified bodies by experts from the Commission and the national authorities. While we have managed to find available experts for 2020, even under the additional constraints imposed by COVID-19 in terms of travel restrictions, it has been a very challenging exercise. Mr Tanel Kiik Minister of Social Affairs Suur-Ameerika 1, 10122 Tallinn Estonia I hope that I can count on your continued commitment in the assessment process, including to ensure that experts can be made available when called upon. This is essential as a lack of assessors will result in risks of delay in the designation of notified bodies, which might have a negative impact on the availability of medical devices on the market. Secondly, I would like to draw your attention to the implementation of the In vitro Diagnostic Medical Devices Regulation (IVDR). While the IVDR only applies from 26 May 2022, the work necessary to set up this system should not be underestimated. The shift of resources and priorities to COVID-19 has inevitably had an impact on the implementation of the IVDR. Yet, the COVID-19 situation has demonstrated the importance of this new legal framework. While today a substantial percentage of the in vitro diagnostic medical device tests, including for COVID-19, are self-declared by manufacturers, the new legal framework will strengthen the rules on conformity assessments and require the involvement of a notified body. It is therefore essential that we take all measures possible to ensure that the implementation can advance smoothly. The key priorities and challenges of the IVDR implementation were discussed in the Medical Devices Coordination Group meeting on 20-21 October 2020 and again on 7-8 December 2020 where a large number of work items and challenges were identified. It will only be possible to address these challenges and follow up on the priorities, if the Commission, Member States and stakeholders collaborate closely together and allocate the necessary resources. I hope I can count on your active contribution and engagement in this important work. Finally, I take the occasion to share with you an observation on the task forces established under the Medical Devices Coordination Group to facilitate the implementation of the medical device legislation. To this date, many of these task forces are lacking a lead Member State, which reduces their effectiveness. The expertise and knowledge from a national perspective are crucial to move the work forward and I ask, here also, for your commitment and cooperation. I thank you for your support and look forward to working with you to ensure the implementation of this important legislative framework to protect the health of all. Yours sincerely, Electronically signed on 16/12/2020 11:27 (UTC+01) in accordance with article 11 of Commission Decision C(2020) 4482
Allikas: Sotsiaalministeerium dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel